Eye-D insert: Phase I/IIa started

Aerie Pharmaceuticals Inc. (NASDAQ:AERI), Bedminster, N.J. Product: Eye-D insert Business: Ophthalmic Molecular target: NA Description: Intraocular controlled-release insert containing latanoprost, a...